HIV in South Africa: Why rolling out a new shot will miss a critical group of men

The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026. Clinical trials showed close to 100% efficacy. The rollout, expected to begin in June 2026, prioritizes adolescent girls and young women, pregnant and breastfeeding women, transgender people,…